文献速递神经肿瘤神经重症

缓慢速率脑室腰大池灌注化疗治疗软脑膜癌病的疗效:一项II期研究

The efficacy of slow-rate ventriculolumbar perfusion chemotherapy for leptomeningeal carcinomatosis: a phase II study.
PubMed 文献 · Acta Neurochir (Wien) · 2024-03-01

这项单臂两阶段II期试验采用Simon极小极大设计,评估降低灌注速率至15 cc/h的脑室腰大池灌注甲氨蝶呤化疗对软脑膜转移患者的症状反应与副作用。90例入组,65例颅内压升高者中32例颅内压恢复正常(偏倚校正缓解率51%);中重度意识模糊发生率较既往20 cc/h研究显著降低(12% vs 23%,p=0.04)。结论认为低灌注速率未能提供非劣效的颅内压控制或改善副作用(意识模糊除外)。

要点

  • 65例颅内压升高患者中32例经灌注化疗后颅内压恢复正常,偏倚校正缓解率为51%。
  • 中重度意识模糊发生率由既往研究的23%显著降至12%(p=0.04)。
  • 中重度恶心呕吐由64%降至46%、睡眠障碍由9%升至13%,均未达统计学显著。

核心结论

  • 与较高灌注速率相比,低灌注速率未能提供非劣效的颅内压控制或改善副作用,仅意识模糊除外。
  • 脑室腰大池灌注速率与颅内压控制的关系需在今后试验中校正因一般状况差而未完成方案所致的偏倚后评估。

研究设计与样本

  • 单臂、两阶段II期试验,基于Simon极小极大设计。
  • 患者接受降低至15 cc/h灌注速率的脑室腰大池灌注甲氨蝶呤化疗,目的是减少恶心呕吐、失眠和意识模糊等全身副作用。
  • 主要结局为颅内压升高的控制,次要结局为副作用发生情况。
  • 结果与既往20 cc/h灌注速率的脑室腰大池灌注试验进行比较。
  • 共入组90例患者。

主要发现

  • 65例颅内压升高患者中,32例在脑室腰大池灌注化疗后颅内压恢复正常,偏倚校正缓解率为51%。
  • 中重度恶心呕吐发生率由既往研究的64%降至46%,睡眠障碍发生率由9%升至13%,两者均未达统计学显著。
  • 中重度意识模糊发生率由既往研究的23%显著降至12%(p=0.04)。
  • 颅内压控制患者的中位总生存优于颅内压仍升高者(193天 vs 94天,p=0.013)。

局限性

  • 原文指出需在今后试验中校正因一般状况差而未完成方案所致的偏倚,以评估灌注速率与颅内压控制的关系。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: This study aimed to evaluate the symptomatic response and side effects of ventriculolumbar perfusion (VLP) methotrexate chemotherapy with a low perfusion rate in patients with leptomeningeal metastasis. METHODS: Patients in a single-arm, two-stage phase II trial based on Simon's minimax design received VLP with a reduced (15 cc/h) perfusion rate with the purpose of decreasing constitutional side effects such as nausea/vomiting, insomnia, and confusion. The primary outcome was control of increased intracranial pressure (ICP). The secondary outcome was an occurrence of side effects. The results were compared with those of a previous trial of VLP with a 20-cc/h perfusion rate. RESULTS: Total 90 patients were enrolled. Out of 65 patients with increased ICP, 32 achieved normalized ICP after VLP chemotherapy (bias-adjusted response rate = 51%). The incidence of moderate-to-severe nausea/vomiting was reduced to 46% from 64% in the previous study, and that of sleep disturbance was increased to 13% from 9%, but both failed to reach statistical significance. The incidence of moderate-to-severe confusion was significantly reduced to 12% from 23% in the previous study (p = 0.04). Median overall survival was better among patients with controlled ICP than among those who remained with increased ICP (193 days vs. 94 days, p = 0.013). CONCLUSION: Compared with a higher perfusion rate, the low perfusion rate failed to provide non-inferior ICP control or improved side effects, except for confusion. The relationship between VLP perfusion rate and ICP control needs to be evaluated in future trials adjusting for bias from uncompleted protocol due to poor general condition.

来源:Acta Neurochir (Wien),查看原文。版权归原作者所有。

引用

  1. Jang S, Gwak HS, Joo J, et al. The efficacy of slow-rate ventriculolumbar perfusion chemotherapy for leptomeningeal carcinomatosis: a phase II study. Acta Neurochir (Wien). 2024. PMID: 38424255. doi:10.1007/s00701-024-05989-0

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。